146 related articles for article (PubMed ID: 27110565)
21. C21ORF105, A chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma.
Go AT; Visser A; Mulders MA; Twisk JW; Blankenstein MA; van Vugt JM; Oudejans CB
Prenat Diagn; 2007 Feb; 27(2):146-9. PubMed ID: 17186567
[TBL] [Abstract][Full Text] [Related]
22. A de novo duplication of chromosome 21q22.11→qter associated with Down syndrome: prenatal diagnosis, molecular cytogenetic characterization and fetal ultrasound findings.
Chen CP; Huang HK; Ling PY; Su YN; Chen M; Tsai FJ; Wu PC; Chern SR; Chen YT; Lee CC; Wang W
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):492-8. PubMed ID: 22212323
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive prenatal diagnosis of Down syndrome: current knowledge and novel insights.
Sifakis S; Papantoniou N; Kappou D; Antsaklis A
J Perinat Med; 2012 Feb; 40(4):319-27. PubMed ID: 22752761
[TBL] [Abstract][Full Text] [Related]
24. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome.
Lim JH; Kim DJ; Lee DE; Han JY; Chung JH; Ahn HK; Lee SW; Lim DH; Lee YS; Park SY; Ryu HM
Placenta; 2015 Mar; 36(3):322-8. PubMed ID: 25595853
[TBL] [Abstract][Full Text] [Related]
26. Identification of dysregulated microRNAs in lymphocytes from children with Down syndrome.
Xu Y; Li W; Liu X; Chen H; Tan K; Chen Y; Tu Z; Dai Y
Gene; 2013 Nov; 530(2):278-86. PubMed ID: 23933415
[TBL] [Abstract][Full Text] [Related]
27. Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women.
Caughey AB; Washington AE; Kuppermann M
Am J Obstet Gynecol; 2008 Mar; 198(3):333.e1-8. PubMed ID: 18177830
[TBL] [Abstract][Full Text] [Related]
28. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
29. Integrated miRNA and mRNA expression profiling in fetal hippocampus with Down syndrome.
Shi WL; Liu ZZ; Wang HD; Wu D; Zhang H; Xiao H; Chu Y; Hou QF; Liao SX
J Biomed Sci; 2016 Jun; 23(1):48. PubMed ID: 27266699
[TBL] [Abstract][Full Text] [Related]
30. [Clinical features of abnormal chromosome karyotypes in twin pregnancies complicated with structural abnormalities].
Zhong SL; Fang Q; Chen BJ; Han ZY; Luo YM; Chen JS; Xie YJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):649-54. PubMed ID: 22176987
[TBL] [Abstract][Full Text] [Related]
31. Antenatal screening for Down's syndrome: where are we and where next?
Haddow JE
Lancet; 1998 Aug; 352(9125):336-7. PubMed ID: 9717914
[No Abstract] [Full Text] [Related]
32. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
33. Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment.
Caine A; Maltby AE; Parkin CA; Waters JJ; Crolla JA;
Lancet; 2005 Jul 9-15; 366(9480):123-8. PubMed ID: 16005334
[TBL] [Abstract][Full Text] [Related]
34. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
[TBL] [Abstract][Full Text] [Related]
35. Maternal mosaicism of sex chromosome causes discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing.
Wang L; Meng Q; Tang X; Yin T; Zhang J; Yang S; Wang X; Wu H; Shi Q; Jenkins EC; Zhong N; Gu Y
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):527-31. PubMed ID: 26522104
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: age-related uptake of prenatal screening and invasive diagnostic testing.
Engels MA; Bhola SL; Twisk JW; Blankenstein MA; van Vugt JM
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():59-63. PubMed ID: 24405726
[TBL] [Abstract][Full Text] [Related]
37. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness].
Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A
Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylated ERG as a cell-free fetal DNA biomarker for non-invasive prenatal testing of Down syndrome.
Chen X; Xiong L; Zeng T; Xiao K; Huang Y; Guo H; Ren J
Clin Chim Acta; 2015 Apr; 444():289-92. PubMed ID: 25749407
[TBL] [Abstract][Full Text] [Related]
39. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data.
Hui L; Muggli EE; Halliday JL
BJOG; 2016 Jan; 123(1):90-7. PubMed ID: 26108969
[TBL] [Abstract][Full Text] [Related]
40. Prenatal diagnosis of de novo unbalanced translocation 8p;21q using subtelomeric probes.
Ozkinay F; Kanit H; Onay H; Cogulu O; Gunduz C; Ercal D; Ozkinay C
Genet Couns; 2006; 17(3):315-20. PubMed ID: 17100200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
